Logos of VivaQuity and ebiga-VISION. VivaQuity is a 100% subsidiary of ebiga-VISION.
Contact Us
Logos of VivaQuity and ebiga-VISION. VivaQuity is a 100% subsidiary of ebiga-VISION.

Floater intervention with VitroCap®N

Monthly package of VitroCap®N 30 vegan capsules food supplement for eye floaters

Order free samples and informational material

We do not have a field service, so we are pleased to send free product samples and information to members of the medical profession. Simply fill in your information to receive your free product samples and informational materials.* 

Sample box for VitroCap®N with a blue label showing a cloud and text reading “Floaters, Vision Degrading Myodesopsia?, Mouches volantes,” along with an image of the VitroCap®N product.

*After the initial delivery, this service is provided every 3 months. You can cancel at any time by emailing info@ebiga-vision.com. If you do not wish to receive quarterly samples, please mention this in the ‘Message’ field of the form.

Your VitroCap®N sample pack

The sample pack available for eye care professionals includes:

  • 18 VitroCap N sample boxes (vegan)
  • ca. 40+/-10 VitroCap N patient brochures
  • 1 VitroCap N brochure holder “Never lose sight…”
  • 1 A4 information for eye care professionals “Observational study…”
  • 1 A4 information for eye care professionals “Flies study proves reduction…”
  • 1 Amsler Grid/Contrast test card
  • 1 postcard “Vitreous Floater”
Contents of the VitroCap®N sample box, including multiple product cartons (containing sample blister packs), patient information leaflets, informational sheets for doctors, a postcard about vitreous floaters, and a contrast sensitivity test.

Why do we provide free product samples and informational materials?

We do not have a field sales team, so we are happy to send free product samples and information to medical professionals.

VitroCap®N is a micronutrient complex, supported by clinical studies. By offering sample shipments, we aim to give you the opportunity to assess the product yourself, provide comprehensive and straightforward advice to your patients, and offer them an evidence-based treatment option

VitroCap®N has been tested in 5 clinical studies

Table summarizing five studies on VitroCap®N showing improvements in visual symptoms, with success rates ranging from 64% to 87%.
Two fundus images of a patient from the FLIES study before and after 6 months of supplementation with VitroCap® N. Yellow outlines mark vitreous opacities, showing a clear reduction in opacity size after supplementation. The text highlights that 77% of patients in the active group showed a decrease in opacity area. Citation of the FLIES study by Ankamah et al., published in Translational Vision Science & Technology (2021).

FLIES study proves reduction of floaters in 77% of patients

Discover more

Are you a healthcare professional?

This content is intended solely for the eyes of healthcare professionals. Please confirm below or visit the offical VitroCap®N website for private customers.

I am a healthcare professional
Visit the offical VitroCap®N page